Sign in to CMS Desk.
  • Contacts
  • About us
AA+
Font size:
FlexEquip
  • Overview
    • Getting started
    • Motor neurone disease
    • About MNDcare
    • News
    • MNDcare approach
    • Participate
    • Online training for service providers
  • Diagnosis
    • Could this be MND?
    • Giving the diagnosis
  • Living with MND
    • Symptom management
    • Wellbeing and support needs
  • End of life
    • Initiating end of life discussions
    • Symptom management at end of life
    • Medications at end of life
    • The carer
    • Bereavement
  • Referral Pathways
  • Getting started
  • Motor neurone disease
    • Phenotypes
    • Presentation
    • Sporadic and familial
    • Disease process
    • Disease process interventions
      • How to treat motor neurone disease
      • Riluzole
      • Other disease process interventions
        • Antioxidants
        • Ciliary neurotrophic factor (CNTF)
        • Creatine
        • Recombinant human insulin-like growth factor I (rhIGF-I)
        • Repetitive transcranial magnetic stimulation (rTMS)
    • Registers
    • Research funding
  • About MNDcare
    • Background and funding
    • MND Associations
    • Disclaimer
    • Acknowledgements
    • Privacy
  • News
    • 8th National Motor Neurone Disease Conference
    • Conferences and Events
    • Invitation to participate in ARC study on the therapeutic use of autologous stem cells (ASCs) in Australia
    • MNDcare latest news
  • MNDcare approach
    • Care coordination
      • Key worker
      • MND Association
      • Care Pathways
    • Review and assess
    • Multidisciplinary
    • Palliative approach
    • Information and discussion
      • For health and community care professionals
        • Al-Chahabi and Hardiman 2013 The epidemiology of ALS: a conspiracy of genes, environment and time
        • Andersen et al. 2007 Good practice in the management of amyotrophic lateral sclerosis: clinical guidelines. An evidence-based review with good practice points. EALSC Working Group
        • Andersen et al. 2012 EFNS guidelines on the Clinical Management of Amyotrophic Lateral Sclerosis (MALS) - revised report of an EFNS task force
        • Aoun et al. 2016 Breaking the news of a diagnosis of motor neurone disease: A national survey of neurologists' perspectives
        • Aoun et al. 2017 Family carers experiences of receiving the news of a diagnosis of motor neurone disease
        • Aoun et al. 2016 Receiving the news of a diagnosis of motor neuron disease: What does it take to make it better?
        • Ashworth et al. 2012 Treatment for spasticity in amyotrophic lateral sclerosis/motor neuron disease
        • Aoun et al. 2012 A 10-year literature review of family caregiving for motor neurone disease: Moving from caregiver burden studies to palliative care interventions
        • Averill et al. 2007 Psychological health in patients with amyotrophic lateral sclerosis
        • Baldinger et al. 2012 Treatment for cramps in amyotrophic lateral sclerosis/motor neuron disease
        • Beauverd et al. 2012 Recombinant human insulin-like growth factor I (rhIGF-I) for the treatment of amyotrophic lateral sclerosis/motor neuron disease
        • Benatar et al. 2009 Treatment for familial amyotrophic lateral sclerosis/motor neuron disease
        • Berlowitz et al. 2013 Identifying who will benefit from non-invasive ventilation in amyotrophic lateral sclerosis/motor neurone disease in a clinical cohort
        • Berlowitz et al. 2016 Identifying who will benefit from non-invasive ventilation in amyotrophic lateral sclerosis motor neurone disease in a clinical cohort
        • Bloomer et al. 2011 End of life care: The importance of advance care planning.
        • Bongioanni et al. 2004 (updated 2009) Neurotrophic factor (CNTF) for amyotrophic lateral sclerosis/motor neuron disease
        • Borasio and Voltz 2006 'Advance directives' in 'Palliative Care in Amyotrophic Lateral Sclerosis from Diagnosis to Bereavement'
        • Brettschneider et al. 2013 Drug therapy for pain in amyotrophic lateral sclerosis or motor neuron disease
        • Carers Australia 2010 Supporting family carers
        • CareSearch
        • Caring Safely at Home
        • Chio et al. 2009 Prognostic factors in ALS: A critical review
        • Clayton et al. 2007 Clinical practice guidelines for communicating prognosis and end-of-life issues with adults in the advanced stages of a life-limiting illness, and their caregivers
        • Cox et al. 2007 Pathogenesis of motor neurone disease
        • Dalbello-Haas and Florence 2013 Therapeutic exercise for people with amyotrophic lateral sclerosis or motor neuron disease
        • Fang et al. 2013 Repetitive transcranial magnetic stimulation for the treatment of amyotrophic lateral sclerosis or motor neuron disease.
        • Gallagher and Monroe 2006 Psychosocial care
        • Hardiman 2007 Multidisciplinary care in motor neurone disease
        • Heffernan et al. 2006 Management of respiration in MND/ALS patients: an evidence based review
        • Hudson et al. Clinical Practice Guidelines for the Psychosocial and Bereavement Support of Family Caregivers of Palliative Care Patients
        • Katzberg et al. 2011 Enteral tube feeding for amyotrophic lateral sclerosis/motor neuron disease
        • Kiernan et al. 2011 Amyotrophic Lateral Sclerosis - Review Article
        • Kinnersley et al. 2007
        • Lambert 2006 Spiritual care
        • Lillo and Hodges 2009 Frontotemporal dementia and motor neurone disease: overlapping clinic-pathological disorders
        • McCabe and O'Connor 2010 Economic impact of neurological illness on well-being
        • McLeod and Clarke 2007 A review of psychosocial aspects of motor neurone disease
        • McMurray and Harris 2006 Bereavement
        • Merrilees et al. 2010 Cognitive and behavioral challenges in caring for people with frontotemporal dementia and amyotrophic lateral sclerosis
        • Miller et al. 2012 Riluzole for amyotrophic lateral sclerosis ALS/motor neuron disease MND
        • Miller et al. 2009a Practice parameter update: The care of the patient with amyotrophic lateral sclerosis: drug, nutritional, and respiratory therapies
        • Miller et al. 2009b Practice parameter update: The care of the patient with amyotrophic lateral sclerosis: multidisciplinary care, symptom management, cognitive/behavioral impairment
        • Miller et al. 2013 Quality improvement in neurology: Amyotrophic lateral sclerosis quality measures
        • Mitchell et al. 2008 Multidisciplinary care planning and teamwork in primary care
        • Mitsumoto et al. 2005 Promoting excellence in end-of-life care in ALS
        • MND Association, 2011, 'Multidisciplinary team working: a best practice guide'
        • MND Australia 2014 Motor neurone disease aspects of care: for the primary health care team
        • MND Australia 2010 Motor neurone disease aspects of care: for staff of residential care facilities
        • Mockford et al. 2006 A review: carers, MND and service provision
        • MND Australia 2017 Motor neurone disease aspects of care: for the primary health care team
        • Murphy 2004 Communication strategies of people with ALS and their partners
        • Murray and McKenzie 2007 Respiratory function in motor neurone disease
        • National End of Life Care Programme, 2010, Improving end of life care in neurological disease a framework for implementation
        • National Institute for Health and Care Excellence 2016 NICE: Guideline on MND Management
        • National Institute for Health and Clinical Excellence 2001 NICE: Guidance on the use of riluzole (Rilutek) for the treatment of motor neurone disease
        • National Institute for Health and Clinical Excellence 2010 NICE: The use of non-invasive ventilation in the management of motor neurone disease
        • Ng et al. 2009 Multidisciplinary care for adults with amyotrophic lateral sclerosis or motor neuron disease
        • Ng et al. 2015 Symptomatic treatments for amyotrophic lateral sclerosis/motor neuron disease
        • Oliver et al. A consensus review on the development of palliative care for patients with chronic and progressive neurological disease.
        • Orrell 2010 Motor neuron disease: systematic reviews of treatment for ALS and SMA
        • Orrell et al. 2007 Antioxidant treatment for amyotrophic lateral sclerosis/motor neuron disease
        • OT Australia 2010
        • Palliative Care and Neurological Conditions Position Statement 2014
        • Palliative Care Australia 2008 Carers and end of life: position statement
        • Pastula et al. 2012 Creatine for Amyotrophic Lateral Sclerosis/Motor Neuron Disease
        • Physiotherapy Practice Research in Motor Neurone Disease
        • Radunovic et al. 2013 Mechanical ventilation for amyotrophic lateral sclerosis/motor neuron disease
        • Rafiq et al. 2012, Respiratory management of motor neurone disease: a review of current practice and new developments
        • Ramirez et al. 2008 Fatigue in amyotrophic lateral sclerosis: frequency and associated factors
        • Ravits et al. 2013 Deciphering amyotrophic lateral sclerosis: What phenotype, neuropathology and genetics are telling us about pathogenesis
        • Rudnicki et al. 2015 Symptom management and end of life care
        • Sackett B and Sakel M, 2011, Motor Neurone Disease - A Patient's Journey
        • Stavroulakis et al. 2013, Gastrostomy use in motor neurone disease (MND): A review, meta-analysis and survey of current practice
        • Stem Cell Treatments - A Quick Guide for Medical Practitioners
        • Stone and O'Leary 2009 Systematic review of the effectiveness of botulinum toxin or radiotherapy for sialorrhea in patients with amyotrophic lateral sclerosis
        • Strong et al. 2009 Consensus criteria for the diagnosis of frontotemporal cognitive and behavioural syndromes in amyotrophic lateral sclerosis
        • Tai et al. 2008 A review of emerging access technologies for individuals with severe motor impairments
        • Talman et al. 2009 Clinical phenotypes and natural progression for motor neuron disease: analysis from an Australian database
        • Talman et al. 2016 Identification and outcomes of clinical phenotypes in amyotrophic lateral sclerosis/motor neuron disease: Australian Motor Neuron Disease observational cohort
        • Tomik and Guiloff 2010 Dysarthria in amyotrophic lateral sclerosis: a review
        • Turner and Al-Chalabi 2007 Clinical phenotypes
        • Turner et al. 2013 Controversies and priorities in Amyotrophic Lateral Sclerosis
        • Vrijsen et al. 2013 Non-invasive ventilation in amyotrophic lateral sclerosis
        • Vucic et al. 2007 Diagnosis of motor neurone disease
        • Young et al. 2011 Treatment for Sialorrhea (excessive saliva) in people with motor neuron disease/amyotrophic lateral sclerosis (review)
        • Zoing 2007 Motor neurone disease: a nurse's perspective
      • For people living with MND
        • Breathing and MND: an introduction - for people living with MND
        • Breathing and MND: medications and non-invasive ventilation - for people living with MND
        • Breathing and MND: what you can do - for people living with MND
        • Carers Kit MND NSW 2007
        • Cognitive and behaviour change in MND
        • Considering gastrostomy - for people living with MND
        • Familial MND and genetic testing - for people living with MND
        • Insomnia MND Vic 2010
        • MND Evidence-based interventions: an overview - for people living with MND
        • Motor Neurone Disease: More Facts - for people living with MND
        • Motor Neurone Disease: Some Facts - for people living with MND
        • Multidisciplinary care: an overview - for people living with MND
        • Multidisciplinary care teams: an overview - for people living with MND
        • Planning Ahead - for people living with MND
        • Riluzole: an overview - for people living with MND
        • Talking with young people about mnd
        • Stem Cell Treatments - Frequently Asked Questions
      • General
        • BBC Radio 4 - Interview with Jane Hawking
        • Contacting your local MND Association
        • Deloitte Access Economics Report 2015 - Economic Analysis of MND in Australia
        • MND Australia 2009 Response to NHHRC interim report - A Healthier Future for all Australians
        • Listening to Janet
        • MND Models of Care
        • MND Patient Rehabilitation Pathway, Neuropalliative Rehabilitation Model of Care
        • Podcast - Dr Amanda Piper, Ask the Experts, Breathing Under Pressure
        • Podcast - Professor Dominic Rowe, Ask the Experts, About MND
        • Podcast - Dr James Burrell, Ask the Experts, What's New in MND Research
        • Statement of good practice for the management of ALS/MND
        • Victorian Government Department of Human Services 2008 Motor neurone disease and palliative care - Interim report on the MND Pathway Project - April 2008
        • Visit the MND Australia website
        • Vodcast - Interview with Dr Peter Martin: Breaking Bad News
        • Vodcast - Interview with Rod Harris: Motor Neurone Disease (MND) and palliative care
        • Tony Judt on having MND
        • Sprituality at End of Life - 2011
        • Zora's Story
        • ABC 7.30 - Familial MND
        • The Last Word: Matt Eustace
        • Understanding the National Relay Service
        • Healthtalkonline
        • Non Invasive Ventilation Training Videos
        • Steve's Story
        • ALS TDI postcards from around the world
        • Motor neurone disease neck collars
        • Science With Chris Smith - RN Breakfast
      • ALS/MND conference presentations
        • 22nd Meeting of the International Alliance of ALS/MND Associations
        • 7th National MND Conference
        • 8th National MND Conference, Melbourne 12 September 2016
        • Ask the Experts December 2016, Dublin
        • MND Connect 2016
        • Ask the Experts, Brussels 2014
        • 25th International Symposium on ALS/MND
        • Allcroft, P. 2012, 'Palliative approach to symptom management in motor neurone disease'
        • Allied Professionals Forum 2012
        • Allied Professionals Forum 2013
        • Allied Professionals Forum 2014
        • ALS TDI Leadership Summit 2013
        • Ask the Experts 2015 - MND NSW
        • Ask the Experts 2011
        • Ask the Experts 2013 MND NSW
        • Baldock, R. 2012, Motor Neurone Disease - Assess, Support, Communicate Project (MND-ASC)
        • Bentley, B. 2012, 'Dignity therapy’s ability to enhance the end of life for people with MND, their families: preliminary results from the dignity therapy/MND study
        • Brennan, F. 2010. 'A palliative approach to MND'
        • Brown, H. 2012, 'Health Pathways: advocacy and innovative service delivery in Motor Neurone Disease'
        • Burrell, J. 2012, 'Cognition in Motor Neurone Disease: The new frontier'
        • Craig, Sue.2012 'There's nothing you don't go through'
        • Dickie, B. 2012, 'Research Today: Implications for Tomorrow'
        • Hogden, A. 2012, 'What influences patients decision-making in MND care?'
        • Jessop, A. 2012, 'Where there’s a Will there’s a Way'
        • Kelly, E. 2012, 'Together we make a difference: multidisciplinary team planning meetings for people living with MND'
        • Lechtzin, N. 2012, 'Diaphragm Pacing in ALS: Turbulent or Transformative'
        • Love, A. 2012, 'Communications technology for people with MND: Current picture and future directions'
        • Miles, K. 2012, 'MND: Living and Caring in the Moment. Coordinating, Anticipating, Responding through an Interdisciplinary Palliative Care Team Approach in Country SA'
        • Erjavic, S. 2010. ‘An Overview of MND’
        • Oliver, D. 2010 'Patients with Cognitive Change - the challenge for families and professionals'
        • Oliver, D. 2010 'Withdrawal of non-invasive ventilation - how can we help all involved?'
        • Schultz, D, 2012, 'Australian Motor Neuron Disease Registry: An Update'
        • Shaw, P. 2012, 'NIV in ALS/MND: Where are we now and where are we going?'
        • Turner, B. 2012, 'Why we can't yet cure MND and what we are doing about it'
        • Wolfe, L. 2012, 'Airway Clearance (AC): Options and Strategies'
        • Wolfe, L. 2010. 'Respiratory update in ALS'
    • Refer
  • Participate
  • Online training for service providers
Overview > MNDcare approach > Information and discussion > For health and community care professionals > Ashworth et al. 2012 Treatment for spasticity in amyotrophic lateral sclerosis/motor neuron disease
RSS Icon Receive our RSS News feed
Bookmark and Share

Ashworth et al. 2012 Treatment for spasticity in amyotrophic lateral sclerosis/motor neuron disease

Ashworth, N. L.; Satkunam, L. E. & Deforge, D. (2012), 'Treatment for spasticity in amyotrophic lateral sclerosis/motor neuron disease.', Cochrane Database Syst Rev(2), CD004156

Free full text access online.

onlinelibrary.wiley.com/doi/10.1002/14651858.CD004156.pub4/pdf

Back to top

Referral Pathways

Click on a state or territory.

Or to search using additional criteria visit Referral Pathways.


Disclaimer Copyright MNDcare

Funded by the Australian Government Department of Health and Ageing
Privacy Policy
Website T&Cs


MND Australia would like to advise Aboriginal and Torres Strait Islander users that this website may contain images or names of deceased persons.